A biomarker helps select the patients who respond best to patritumab deruxtecan in breast cancer
A study promoted by SOLTI and published in Nature Communications describes the tumour biology associated with the activity of the drug patritumab der1
A study promoted by SOLTI and published in Nature Communications describes the tumour biology associated with the activity of the drug patritumab der1
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Programme1
On 27 June 2024, a social return event was held at the TV3 facilities, thanking the public for the television marathon devoted to cancer.
The DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that u1
Ten IDIBAPS groups are looking for candidates to apply for one of the pre-doctoral scholarships offered by the INPhINIT program of La Caixa Foundatio1
IDIBAPS looks for talented professionals to meet the needs that appear periodically.
Enter